Biolase
BIOL
#10025
Rank
NZ$0.73 M
Marketcap
$0.02009
Share price
0.00%
Change (1 day)
-99.20%
Change (1 year)
Categories

Operating Margin for Biolase (BIOL)

Operating Margin as of November 2024 (TTM): -58.86%

According to Biolase 's latest financial reports and stock price the company's current Operating Margin is -58.86%. At the end of 2022 the company had an Operating Margin of -58.86%.

Operating Margin history for Biolase from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2022-58.86%43.33%
2021-41.07%-43.99%
2020-73.31%54.82%
2019-47.35%1.88%
2018-46.48%25.12%
2017-37.15%26.46%
2016-29.38%-29.15%
2015-41.46%5.03%
2014-39.48%91.29%
2013-20.64%301.94%
2012-5.13%-42.95%
2011-9.00%-80.27%
2010-45.62%596.99%
2009-6.54%-53.05%
2008-13.94%31%
2007-10.64%63.82%
2006-6.49%-76.65%
2005-27.82%91.7%
2004-14.51%-198.99%
200314.66%166.73%
20025.50%-170.99%
2001-7.74%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
16.60%-128.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-4.41%-92.51%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.